What's Happening?
The Texas Rangers have signed right-handed pitcher Declan Cronin, who previously played for the Miami Marlins. Cronin is recovering from Tommy John surgery and is expected to miss the entire 2026 season.
The Rangers are likely looking at a two-year deal, allowing Cronin to rehabilitate with their training staff in the first year and return to play in 2027. Cronin has a history of injuries, including a knee injury in 2024 and a hip problem in 2025, followed by elbow surgery. Despite these setbacks, Cronin has shown potential, striking out 9.2 batters per nine innings with a 4.35 ERA during his time with the Marlins.
Why It's Important?
The signing of Declan Cronin by the Texas Rangers represents a strategic move to bolster their pitching roster in the long term. While Cronin's injury history poses a risk, his ability to strike out batters at a high rate makes him a valuable asset if he can return to form. This decision reflects the Rangers' willingness to invest in potential future performance rather than immediate results. If Cronin successfully recovers, he could significantly enhance the Rangers' bullpen, providing them with a competitive edge in future seasons.
What's Next?
Cronin will spend the upcoming season rehabilitating under the guidance of the Rangers' medical and training staff. The team will monitor his progress closely, aiming for a successful return to the mound in 2027. The Rangers may also explore additional signings to strengthen their pitching lineup while Cronin recovers. Fans and analysts will be watching to see how Cronin's recovery progresses and whether he can fulfill the potential that the Rangers see in him.
